Diaclone

Mouse Anti-Human CD19 Monoclonal Antibody, Clone B-C3, Azide free

Product Code:
 
854.140.000
Product Group:
 
Primary Antibodies
Supplier:
 
Diaclone
Host Type:
 
Mouse
Antibody Isotype:
 
IgG1
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
B-C3
Regulatory Status:
 
RUO
Target Species:
 
Human
 

No additional charges, what you see is what you pay! *

CodeSizePrice
854.140.000200ug/200ul£232.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: France.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Antigen:
CD19
Conjugate:
Azide free
Format:
Phosphate-buffered saline. Sterile-filtered through 0.22 µm. Carrier and preservative free
Hybridoma:
Myeloma X63/AG.8653 x Balb/c spleen cells
Immunisation:
Chronic Lympho?d Leukaemia (CLL) cells
Reactivity:
Human
Research Area:
B Cell AntigensCD Markers
Specificity:
Recognises a 95 kDa protein
Workshop:
IV

References

  1. Amigo-Jimenez I. et al.Oncotarget2015; 6(42): 44832-48. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kdelta or PKCbeta signaling pathways.. https://www.ncbi.nlm.nih.gov/pubmed/26540567
  2. Amigo-Jimenez I. et al.PLoS One2014; 9(6): e99993.. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.. https://www.ncbi.nlm.nih.gov/pubmed/24956101
  3. Di Meglio P. et al.PLoS One2011;6(2): e17160. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans.. https://www.ncbi.nlm.nih.gov/pubmed/21364948
  4. Jiang S. et al. Blood 2003; 102( 6): 2180 - 2186. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. https://www.ncbi.nlm.nih.gov/pubmed/12775574
  5. Mohty M et al. Int.Immunol. 2002; 14(7) : 741 - 750. Generation of potent T(h)1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cells. https://www.ncbi.nlm.nih.gov/pubmed/12096033
  6. Mohty M et al. J.Immunol. 2003; 171(7) : 3385 - 3393. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. https://www.ncbi.nlm.nih.gov/pubmed/14500632
  7. Mohty M. et al. J Leukoc Biol.2002; 72(5): 939-45.. Differential regulation of dendritic cell function by the immunomodulatory drug thalidomide. https://www.ncbi.nlm.nih.gov/pubmed/12429715
  8. Tiberghien P. et al. Blood 2001; 97(1) : 63 -72. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. https://www.ncbi.nlm.nih.gov/pubmed/11133743
  9. Vermot-Desroches C. et al. Cell Immunol. 2005;236(1-2):101-4. Monoclonal antibodies specific for the IL-18 receptor. https://www.ncbi.nlm.nih.gov/pubmed/16157318